Wordt geladen...
Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is induced by the BCR-ABL oncogene, a product of Philadelphia (Ph) chromosome. The BCR-ABL kinase inhibitor imatinib is a standard treatment for Ph(+) leukemia, and has been shown to induce a complete hematologic and cytogenetic response in most chronic phrase CML pati...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3136127/ https://ncbi.nlm.nih.gov/pubmed/20184539 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|